Exclusive

Publication

Byline

Divi's Labs Q1 preview: Strong topline growth, margin expansion

New Delhi, Aug. 6 -- Divi's Laboratories Ltd, India's second-largest pharmaceutical company by market capitalization, is expected to report a 14-18% jump in revenue and robust margin expansion for the... Read More


Divi's Laboratories' June-quarter profit, margin miss estimates

Mumbai, Aug. 6 -- Contract development and manufacturing organization (CDMO) Divi's Laboratories Ltd's June-quarter earnings missed estimates due to pricing pressure on its generics business. While t... Read More


Eris Lifesciences betting on insulin expertise to boost its GLP-1 play

New Delhi, Aug. 5 -- Eris Lifesciences is gearing up to take advantage of India's booming diabetes-obesity market. The Ahmedabad-based drugmaker stands to gain in the country's human insulin market as... Read More


Sun Pharma net profit falls on US antitrust settlement, drug impairment costs

New Delhi, July 31 -- Sun Pharmaceutical Industries Ltd's revenue from operations for the April-June period beat Street expectations to rise 9.4% year-on-year to Rs.13,851 crore. However, the drugmake... Read More


Sun Pharma Q1 preview: High domestic, global specialty biz growth to boost revenue

New Delhi, July 31 -- An uptick in Sun Pharmaceutical Industries Ltd's domestic business and robust growth in its global specialty business are expected to boost the company's earnings for the June qu... Read More


Jashvik Capital acquires stake in pharma software provider Marg ERP for over Rs.400 crore

New Delhi, July 30 -- Private equity firm Jashvik Capital said on Wednesday that it has acquired a stake in pharma software provider Marg ERP for over Rs.400 crore, marking the firm's fourth investmen... Read More


Piramal Pharma's loss narrows to Rs82 crore in June quarter

Mumbai, July 29 -- Piramal Pharma Ltd will focus on increasing capacities for its contract development and manufacturing business, its largest revenue driver, even as it expects muted growth in 2025-2... Read More


Torrent aims to be among first cos to launch Wegovy, Ozempic generics in Brazil

New Delhi, July 28 -- Torrent Pharmaceuticals Ltd aims to be in the first wave of generic launches of Novo Nordisk's weight-loss drugs Wegovy and Ozempic in Brazil starting next year, the company's ma... Read More


Indian CRDMOs timed their IPOs right. But is the business worth the premium?

New Delhi, July 28 -- An anticipated shift in the global pharmaceutical supply chain away from China has investors excited about Indian contract research, development and manufacturing organisations (... Read More


Indian contract drug makers timed their IPOs right. But is the business worth the premium?

New Delhi, July 28 -- An anticipated shift in the global pharmaceutical supply chain away from China has investors excited about Indian contract research, development and manufacturing organisations (... Read More